3-D printed device delivers drugs in humans

Their demonstration of a 3-D printed wearable oral delivery device in humans represents notable progress in the broader effort to transition 3-D-printed drug delivery devices from the laboratory to the clinic.

3-D printing holds great promise for the pharmaceutical field where it could allow for personalised drug delivery systems to be efficiently created, featuring controllable drug release patterns not currently possible to fight i.e. oral inflammations. To date, only single or combinations of multiple drugs have been used in 3-D printing-related efforts to deliver drugs, which the authors believe is a mere fraction of this technique’s potential.

Applying a two-step fabrication process, first author Kun Liang et al. used 3-D printing to create a structure that is particularly customizable based on tooth impressions, for drug delivery for oral diseases. In an in vitro test, they evaluated it with clobetasol propionate, an anti-inflammatory corticosteroid alleviating oral inflammation; it was released reliably over two weeks. In a Phase I study in six human volunteers, the drug was replaced with the flavor substitute vanillic acid. Wearers tested different vanilla-infused mouth guard prototypes for two hour-periods over three consecutive days; delivery was also sustained, the researchers report.

The mouth guard achieves its highly controlled release through a design that varies the polymer composition to produce special, sensitive filaments. The entire process of printing it for use in human volunteers took two hours, say the authors, which is notably faster than traditional casting and molding techniques for standard mouth guards. This 3-D printing fabrication process can be applied to other devices, the authors say.